COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 509: Articles 5081-5090  | Next

Associations of COVID-19 Symptoms with Omicron Subvariants BA.2 and BA.5, Host Status, and Clinical Outcomes: A Registry-Based Observational Study in Sapporo, Japan
Nakakubo, S., Kishida, N., Okuda, K., Kamada, K., Iwama, M., Suzuki, M., Yokota, I., Ito, Y. M., Nasuhara, Y., Boucher, R. C., Konno, S.
10.1101/2023.02.02.23285393 — Posted: 2023-02-07
Longitudinal and Quantitative Fecal Shedding Dynamics of SARS-CoV-2, Pepper Mild Mottle Virus and CrAssphage
Arts, P. J., Kelly, J. D., Midgley, C. M., Anglin, K., Lu, S., Abedi, G. R., Andino, R. N., Bakker, K. M., Banman, B., Boehm, A., Briggs-Hagen, M., Brouwer, A. F., Davidson, M. C., Eisenberg, M. C., Garcia Knight, M. A., Knight, S., Peluso, M. J., Pineda-Ramirez, J., Tassetto, M., Diaz-Sanchez, R., Saydeh, S., Martin, J. N., Wigginton, K. R.
10.1101/2023.02.02.23285391 — Posted: 2023-02-07
Safety, Virology, Pharmacokinetics, and Clinical Experience of High-dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-label Clinical Trial
Moya, J., Temech, M., Parra, S., Juarez, E., Hernandez-Loy, R., Moises Gutierrez, J. C., Diaz, J., Hussain, R., Segal, S., Xu, C., Skingsley, A., Schnell, G., El-Zailik, A., Sager, J. E., Aldinger, M., Alexander, E. L., Acloque, G.
10.1101/2023.02.02.23285352 — Posted: 2023-02-07
Bioinformatic analysis of the spike protein cleavage sites of coronaviruses in the mammalian order Eulipotyphla
Guo, Q., Choi, A., Millet, J., Whittaker, G.
10.1101/2023.02.05.527216 — Posted: 2023-02-06
Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
Painter, M. M., Johnston, T. S., Lundgreen, K. A., Santos, J. J. S., Qin, J. S., Goel, R. R., Apostolidis, S. A., Mathew, D., Fulmer, B., Williams, J. C., McKeague, M. L., Pattekar, A., Goode, A., Nasta, S., Baxter, A. E., Giles, J. R., Skelly, A. N., Felley, L. E., McLaughlin, M., Weaver, J., Penn Medicine BioBank, , Kuthuru, O., Dougherty, J., Adamski, S., Long, S., Kee, M., Clendenin, C., da Silva Antunes, R., Grifoni, A., Weiskopf, D., Sette, A., Huang, A. C., Rader, D. J., Hensley, S. E., Bates, P., Greenplate, A. R., Wherry, E. J.
10.1101/2023.02.05.527215 — Posted: 2023-02-06
Disease severity of unvaccinated SARS-CoV-2 positive adults less than 65 years old without comorbidity, in the Omicron period and pre-Omicron periods
Wahlstrom, E., Bruce, D., Bennet-Bark, A. M., Walther, S., Hanberger, H., Stralin, K.
10.1101/2023.02.02.23285377 — Posted: 2023-02-06
A Rapid review on the COVID-19 Pandemic's Global Impact on Breast Cancer Screening Participation Rates and Volumes from January-December 2020
Lee, R., UNCOVER, , Xu, W., International Partnership for Resilience in Cancer Systems (I-PaRCS), Breast Cancer Working Group 2, , Dozier, M., McQuillan, R., Theodoratou, E., Figueroa, J.
10.1101/2023.02.06.23285513 — Posted: 2023-02-06
Taxonomical and ontological analysis of verified natural and laboratory human coronavirus hosts
Wang, Y., Ye, M., Zhang, F., Freeman, Z. T., Yu, H., Ye, X., He, Y.
10.1101/2023.02.05.527173 — Posted: 2023-02-06
Automated Agnostic Designation of Pathogen Lineages
McBroome, J., de Bernardi Schneider, A., Roemer, C., Wolfinger, M. T., Hinrichs, A. S., O'Toole, A. N., Ruis, C., Turakhia, Y., Rambaut, A., Corbett-Detig, R.
10.1101/2023.02.03.527052 — Posted: 2023-02-05
Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C)
Yadaw, A. S., Afzali, B., Hotaling, N., Sidky, H., Pfaff, E. S., Sahner, D. K., Mathe, E. A.
10.1101/2023.02.02.23285353 — Posted: 2023-02-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).